Inventor · Paris, FR

Hartmut Ehrlich

29Patents
7h-index
42Co-inventors
69Inventor score

Filing activity: Dec 4, 1987 → Dec 6, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US4992373A Vectors and compounds for direct expression of activated human protein C Chemistry; Metallurgy 43 Expired
US8450275B2 TFPI inhibitors and methods of use Physics 12 Active
US8466108B2 TFPI inhibitors and methods of use Emerging Cross-Sectional Technologies 10 Active
US5196322A Vectors and compounds for expression of zymogen forms of human protein C Chemistry; Metallurgy 10 Expired
US10201586B2 TFPI inhibitors and methods of use Physics 10 Active
US8962912B2 Transgenic non-human animals expressing human blood clotting factors and uses thereof Human Necessities 10 Active
US7968293B2 IVIG modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease Chemistry; Metallurgy 9 Active
US9512198B2 FVIII peptides for immune tolerance induction and immunodiagnostics Chemistry; Metallurgy 5 Active
US8969524B2 FVIII peptides for immune tolerance induction and immunodiagnostics Chemistry; Metallurgy 5 Active
US8216793B2 Detection of antibody that binds to water soluble polymer-modified polypeptides Physics 3 Active
US9463237B2 Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses Chemistry; Metallurgy 3 Active
US9018167B2 TFPI inhibitors and methods of use Physics 3 Active
US8852874B2 Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro Physics 2 Active
US10329583B2 Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses Chemistry; Metallurgy 1 Active
US11001613B2 TFPI inhibitors and methods of use Emerging Cross-Sectional Technologies 1 Active
US9556230B2 TFPI inhibitors and methods of use Physics 1 Active
US9777051B2 TFPI inhibitors and methods of use Emerging Cross-Sectional Technologies 1 Active
US11992499B2 Quinoline derivatives for use in the treatment of inflammation diseases Chemistry; Metallurgy 0 Active
US11266667B2 ABX196 for use in the treatment of bladder cancer Human Necessities 0 Active
US9884105B2 Production of viral vaccine Chemistry; Metallurgy 0 Active
US9046536B2 Methods and compositions for treating bleeding disorders Emerging Cross-Sectional Technologies 0 Active
US11826372B2 Combinations including ABX196 for the treatment of cancer Chemistry; Metallurgy 0 Active
US8986670B2 IgG stimulated remyelination of peripheral nerves Emerging Cross-Sectional Technologies 0 Active
US8632991B2 Methods and compositions for treating bleeding disorders Emerging Cross-Sectional Technologies 0 Active
US11278552B2 Combinations including ABX196 for the treatment of cancer Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.